13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The ability to identify potential responders to neoadjuvant treatment may improve patient selection or surgery and may help in the development of response criteria suitable for routine monitoring of response. The aim of this study was to evaluate the value of PET in predicting the pathological tumour response of non-small-cell lung cancer (NSCLC) to neoadjuvant therapy using a meta-analysis.

          Related collections

          Author and article information

          Journal
          Nucl Med Commun
          Nuclear medicine communications
          1473-5628
          0143-3636
          Jan 2013
          : 34
          : 1
          Affiliations
          [1 ] Department of Nuclear Medicine, Shanghai Institute of Gastrointestinal Diseases, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
          Article
          10.1097/MNM.0b013e3283599999
          23086204
          6706f52f-0236-4630-9f6c-a11e1c1f1f7a
          History

          Comments

          Comment on this article